Price Move History
- Daily moves over 5%
- 50 96 sessions, September 18, 2025 to September 21, 2026
- Largest daily move
- +11000% close of September 16, 2026
- 1-year change
- -77.8% closing prices, September 18, 2025 to September 21, 2026
- 1-month change
- +11000% closing prices, August 21, 2026 to September 21, 2026
Company Description
PANBELA THERAPEUTICS (OTC: PBLA) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $242.7K.
PBLA has declined 77.8% over the past year. The last closing price was $0.0111.
This page collects what Stock Titan holds for PBLA, including price data, latest news, and short interest trends.
Stock Performance
PANBELA THERAPEUTICS (PBLA) closed at $0.0111 on September 21, 2026. Over the past 12 months, the price has lost 77.8%.
PBLA Metrics & Rankings
Price returns through September 21, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
PANBELA THERAPEUTICS has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 5 with negative movement. Key topics include earnings, conferences, clinical trial. View all PBLA news →
SEC Filings
Short Interest History
Short interest in PANBELA THERAPEUTICS (PBLA) currently stands at 3 shares, representing 0.0% of the float. Since October 2025, short interest has increased by 200.0%.
Days to Cover History
Days to cover for PANBELA THERAPEUTICS (PBLA) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume.
PBLA Company Profile & Sector Positioning
PANBELA THERAPEUTICS (PBLA) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing PBLA often look at related companies in the same sector, including VINCERX PHARMA INC (VINC), TREVENA INC (TRVN), ALTAMIRA THERAPEUTICS LTD (CYTOF), RESPIRERX PHARMA INC (RSPI), and SCORPIUS HOLDINGS INC (SCPX). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate PBLA's relative position within its industry.